Specific Inhibition of Coxsackievirus B3 Translation and Replication by Phosphorothioate Antisense Oligodeoxynucleotides
Open Access
- 1 April 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (4) , 1043-1052
- https://doi.org/10.1128/aac.45.4.1043-1052.2001
Abstract
The 5′ and 3′ untranslated regions (UTRs) of coxsackievirus B3 (CVB3) RNA form highly ordered secondary structures that have been confirmed to play important regulatory roles in viral cap-independent internal translation initiation and RNA replication. We previously demonstrated that deletions in different regions of the 5′ UTR significantly reduced viral RNA translation and infectivity. Such observations suggested strongly that viral RNA translation and replication could be blocked if highly specific antisense oligodeoxynucleotides (AS-ODNs) were applied to target crucial sites within the 5′ and 3′ UTRs. In this study, seven phosphorothioate AS-ODNs were synthesized, and the antiviral activity was evaluated by Lipofectin transfection of HeLa cells with AS-ODNs followed by infection of CVB3. Analysis by Western blotting, reverse transcription-PCR, and viral plaque assay demonstrated that viral protein synthesis, genome replication, and infectivity of CVB3 were strongly inhibited by the AS-ODNs complementary to different regions of the 5′ and 3′ UTRs. The most effective sites are located at the proximate terminus of the 5′ UTR (AS-1), the proximate terminus of the 3′ UTR (AS-7), the core sequence of the internal ribosome entry site (AS-2), and the translation initiation codon region (AS-4). These AS-ODNs showed highly sequence-specific and dose-dependent inhibitory effects on both viral protein synthesis and RNA replication. It is noteworthy that the highest inhibitory activities were obtained with AS-1 and AS-7 targeting the termini of the 5′ and 3′ UTRs. The percent inhibition values of AS-1 and AS-7 for CVB3 protein VP1 synthesis and RNA replication were 70.6 and 79.6 for AS-1 and 73.7 and 79.7 for AS-7, respectively. These data suggest that CVB3 infectivity can be inhibited effectively by AS-ODNs.Keywords
This publication has 84 references indexed in Scilit:
- Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequenceArchiv für die gesamte Virusforschung, 1997
- Inhibition of Influenza Virus RNA Polymerase and Nucleoprotein Genes Expression by Unmodified, Phosphorothioated, and Liposomally Encapsulated OligonucleotidesBiochemical and Biophysical Research Communications, 1996
- Specific Interaction of Glyceraldehyde 3-Phosphate Dehydrogenase with the 5′-Nontranslated RNA of Hepatitis A VirusJournal of Biological Chemistry, 1996
- Progress in Antisense Oligonucleotide TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- In VivoInhibition of Hepatitis B Virus Gene Expression by Antisense Phosphorothioate OligonucleotidesBiochemical and Biophysical Research Communications, 1996
- The state of the art in antisense researchNature Medicine, 1995
- Relationship between the presence of circulating anti-GOR and hepatitis C viremia/genotypeJournal of Hepatology, 1995
- Evolving concepts of cause, consequence, and control in myocarditisCurrent Opinion in Cardiology, 1991
- Dilated Cardiomyopathies of the AdultNew England Journal of Medicine, 1982
- Viral Myocarditis and its SequelaeAnnual Review of Medicine, 1973